{"id":620048,"date":[{"year":1981,"month":9,"day":21}],"page":"2","source":"本报","region":"","masthead":"","special_issue":"","column":"","genre":"","count":"308","ytitle":"","mtitle":"张有望　刘尚廉攻克肿瘤诊断一大难题","ftitle":"采用EB病毒免疫酶标法诊断颈部转移癌","authors":["陈耀坤"],"text":[{"type":"paragraph","text":"本报讯　上海第一医学院肿瘤医院放射治疗科主治医师张有望和病理科副教授刘尚廉，合作研究EB病毒免疫酶标法早期诊断原发部位不明的颈部转移癌获得成效。一年多来，采用该法对六十九例原发部位不明的颈部转移癌患者作检测，检出原发部位者达到百分之六十三点八。"},{"type":"paragraph","text":"这种癌的诊断是肿瘤诊断学中的一大难题，据国外有关文献记载，其诊断明确率为百分之三十六点四。过去，国内采用的免疫荧光法容易发生假阳性，灵敏度低，掌握不好会造成误诊。"},{"type":"paragraph","text":"采用EB病毒免疫酶标法诊断颈部转移癌，具有特异性强、灵敏度高、操作简便、便于掌握推广等优点，在一般医院的化验室内均能开展。"},{"type":"paragraph","text":"(通讯员　陈耀坤)"}]}